Evidence map›Paper›PMID 28224459›Full record

ReviewCurrent topics in behavioral neurosciences2018

Effect of Hallucinogens on Unconditioned Behavior.

Adam L Halberstadt, Mark A Geyer

Open access · greenAbstract readReview
In one paragraph

Review in Current topics in behavioral neurosciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
26.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 98 citations in OpenAlex.

  1. Review
  2. Article
  3. Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin.bioRxiv : the preprint server for biology · 2026
    Article
  4. AI-derived therapeutic development of a serotonin receptor-targeting drug for the treatment of opioid use disorder.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Article
  7. Discovery of Highly Selective 5-HTJournal of medicinal chemistry · 2025
    Article
  8. The Selective Serotonin 5‑HTACS pharmacology & translational science · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Molecular and Medical Aspects of Psychedelics.International journal of molecular sciences · 2023
    Review
  19. Review
  20. The crosstalk between 5-HTNeuropharmacology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adam L HalberstadtDepartment of Psychiatry, University of California San Diego, La Jolla, CA, 92093-0804, USA. ahalberstadt@ucsd.edu.
Mark A GeyerDepartment of Psychiatry, University of California San Diego, La Jolla, CA, 92093-0804, USA.
University of California, San Diego · US

Funding

MONOAMINES &HALLUCINOGENS'EFFECTS ON RAT BEHAVIORR01DA002925 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GEYER, MARK A · 1985 to 2015
$4.2M
The Next Generation of Hallucinogens: A New Class of Synthetic Psychoactive DrugsR01DA041336 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HALBERSTADT, ADAM L. · 2017 to 2020
$1.4M
Role of the prefrontal cortex in serotonergic modulation of interval timingK01MH100644 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HALBERSTADT, ADAM L. · 2014 to 2016
$466k
NIDA NIH HHS R01 DA002925NIDA NIH HHS R01 DA041336NIMH NIH HHS K01 MH100644
6 · The paper itself

Abstract

Because of the ethical and regulatory hurdles associated with human studies, much of what is known about the psychopharmacology of hallucinogens has been derived from animal models. However, developing reliable animal models has proven to be a challenging task due to the complexity and variability of hallucinogen effects in humans. This chapter focuses on three animal models that are frequently used to test the effects of hallucinogens on unconditioned behavior: head twitch response (HTR), prepulse inhibition of startle (PPI), and exploratory behavior. The HTR has demonstrated considerable utility in the neurochemical actions of hallucinogens. However, the latter two models have clearer conceptual bridges to human phenomenology. Consistent with the known mechanism of action of hallucinogens in humans, the behavioral effects of hallucinogens in rodents are mediated primarily by activation of 5-HT

Indexed as

AnimalsBehaviorBehavior, AnimalExploratory BehaviorHallucinogensHumansMiceModels, AnimalRatsSensory GatingSerotonin 5-HT2 Receptor AgonistsHallucinogensSerotonin 5-HT2 Receptor Agonists1-methylpsilocin25CN-NBOH25I-NBOMe5-HT2C receptorDOILisurideLocomotor activityLSDLysergic acid diethylamideM100907MescalineMousePsilocybinPsychedelicQuipazineRatSB-242,084Wet dog shake

Identifiers

PMID28224459
PMCPMC5787039
OpenAlexW2590821743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.